The economic benefits of personalised glucose control

12 Dec 2017


Personalised glycaemic control in the treatment of type 2 diabetes patients could save billions in healthcare, a study in the Annals of Internal Medicine suggests.

MedPage Today


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story